Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US

Research
Written By Christine Briscoe

Authors: Chuka Udeze, Michelle Jerry, Kristin Evans, Nanxin Li, Siddharth Jain, & Biree Andemariam

Published: November 24, 2025

Click Here to Read More
Christine Briscoe
Previous

Increasing ketamine administration in children's hospitals for youth with sickle cell disease
Next

Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical Trial